The SARS-CoV-2 vaccine provides cross-protection to the unvaccinated: Study
Along with vaccinated individuals, the SARS-CoV-2 vaccine also protects the unvaccinated people within the locality, according to a study published in the Nature Medicine journal.
COVID-19 is a disease caused by a novel strain of coronavirus, named SARS-COV-2. In COVID-19 'CO' refers to Corona, 'VI' for the virus, and 'D' for disease. Formerly, this disorder was also referred to as '2019 novel coronavirus' or '2019-nCoV.' In the year 2021, many countries worldwide developed vaccines against the SARS-COV-2 virus and have conducted mass vaccinations in their respective countries.
A ton of recent studies have put forth the significance of mass vaccination in controlling the spread of the deadly COVID-19 virus, by providing the necessary protection to the people receiving either one or two doses of the vaccine. Also, a study has pointed out the effectiveness of the BNT162b vaccine from Pfizer–BioNTech in preventing not only the vaccinated but also the non-vaccinated in the community. However, it is not possible to observe this putative effect, especially during the highly fluctuating spatiotemporal epidemic changes.
An observational study was conducted by Milman O et. al wherein they evaluated the complete vaccination records as well as test results that were obtained during the mass vaccine program within a pretty large population.
Following which they found that from over 177 geographically defined localities, the number of vaccines administered within each community was strongly linked with a substantial later reduction in the positivity rate among a cohort of participants belonging to the under 16 age group, who were not vaccinated.
For every 20 percentage points of people who received vaccination in any define region/locality/ community, the COVID-19 positivity rate within the unvaccinated population decreased approximately twice the number.
Thus, the researchers concluded through substantial observational proof, SARS-COV2 vaccination not only protects people who have received the doses but also provides cross-protection to unvaccinated people within the community.
Reference:
A study titled, "Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals" by Milman O et. al published in the Nature Medicine journal.
DOI: 10.1038/s41591-021-01407-5
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.